Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: The atherosclerosis risk in communities study, 1987-1998

Circulation

Volumn 107, Issue 17, 2003, Pages 2190-2195

  Carnethon, Mercedes R ^a   Golden, Sherita H ^b   Folsom, Aaron R ^c   Haskell, William ^d   Liao, Duanping ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Epidemiology; Heart rate; Nervous system, autonomic

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC NEUROPATHY; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART RATE VARIABILITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; SURVIVAL RATE; TREATMENT OUTCOME;

ARTERIOSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; FEMALE; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0038711037     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000066324.74807.95     Document Type: Article

References (34)

1. Carnethon MR, Liao D, Evans GW, et al. Correlates of the shift in heart rate variability with an active postural change in a healthy population sample: the Atherosclerosis Risk in Communities Study. Am Heart J. 2002;143:808-813.
2. Liao D, Cai J, Brancati FL, et al. Association of vagal tone with serum insulin, glucose, and diabetes mellitus: the ARIC study. Diabetes Res Clin Pract. 1995;30:211-221.
3. Singh JP, Larson MG, O'Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (the Framingham Heart Study). Am J Cardiol. 2000;86:309-312.
4. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 2000;43:533-549.
5. Shimazu T. Innervation of the liver and glucoregulation: the role of the hypothalamus and autonomic nerves. Nutrition. 1996;12:65-66.
6. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-382.
7. Festa A, D'Agostino R Jr, Hales CN, et al. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000;23:624-628.
8. Panzer C, Lauer MS, Brieke A, et al. Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes. 2002;51:803-807.
9. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med. 1997;24:321-336.
10. Ito H, Ohshima A, Tsuzuki M, et al. Effects of increased physical activity and mild calorie restriction on heart rate variability in obese women. Jpn Heart J. 2001;42:459-469.
11. Melanson EL, Freedson PS. The effect of endurance training on resting heart rate variability in sedentary adult males. Eur J Appl Physiol. 2001; 85:442-449.
12. ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989;129:687-699.
13. Jackson R, Chambless LE. Yang K, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity: the Atherosclerosis Risk In Communities Study Investigators. J Clin Epidenmiol, 1996;49:1441-1446.
14. National Heart, Lung, and Blood Institute. Manual 1: general description and study management. In: Atherosclerosis Risk in Communities Study Protocol. Version 3.0. Chapel Hill, NC: University of North Carolina at Chapel Hill, ARIC Coordinating Center (CSCC); 1997.
15. Liao D, Barnes RW. Chambless LE, et al. A computer algorithm to impute interrupted heart rate data for the spectral analysis of heart rate variability: the ARIC Study. Comput Biomed Res. 1996:29:140-151.
16. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-1065.
17. Akselrod S. Components of heart rate variability: basic studies. In: Malik M, Camm AJ. eds. Heart Rate Variability. Armonk, NY: Futura Publishing Co; 1995:147-163.
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
19. Baecke J, Burema J, Frijters J. A short questionnaire for the measurement of habitual physical activity in epidemiologic studies. Am J Clin Nutr. 1982;36:936-942.
20. Brancati FL, Kao WHL, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk In Communities Study. JAMA. 2000:283:2253-2259.
21. Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med. 2000;342:905-912.
22. Meigs JB, Nathan DM, Wilson PW. et al. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study, Ann Intern Med. 1998:128:524-533.
23. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995:18:258-268.
24. Benthem L, Keizer K. Wiegman CH, et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab. 2000:279:E1286- E1293.
25. Watkins L, Surwit R, Grossman P, et al. Is there a glycemic threshold for impaired autonomic control? Diabetes Care. 2000;23:826-830.
26. Blomqvist CG, Saltin B. Cardiovascular adaptations to physical training. Annu Rev Physiol. 1983;45:169-189.
27. Wei M, Gibbons LW, Mitchell TL, et al, The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med. 1999;130:89-96.
28. Boule NG, Haddad E, Kenny GP, et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286:1218-1227.
29. Carnethon MR, Liao D, Evans GW, et al. Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality? The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2002;155:48-56.
30. Liao D, Cai J, Rosamond WD, et al. Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study: the ARIC study. Am J Epidemiol. 1997;145:696-706.
31. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation. 1996;94:2850-2855.
32. Tsuji H, Venditti F Jr, Manders E, et al. Reduced heart rate variability and mortality risk in an elderly cohort: the Framingham Heart Study. Circalation. 1994:90:878-883,
33. Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol. 1993;72:821-822.
34. Deliargyris EN, Nesto RW. Autonomic neuropathy and heart disease. In: Veves A, ed. Clinical Management of Diabetic Neuropathy. Totowa, NJ: Humana Press; 1998:209-226.